The G22A polymorphism of the ADA gene and susceptibility to autism spectrum disorders.

Scientists looked at one tiny DNA change called G22A in the ADA gene. They asked if this change is more common in kids with autism than in kids without it.

Families from North America gave blood samples. The team compared the gene version between children with autism and healthy controls.

The G22A version showed up just as often in both groups. It did not raise autism risk.

The only blip was a slight increase in how often dads passed the version to affected kids. This hint was too small to matter for families.

Pu et al. (2013) pooled eight studies and found the MTHFR C677T version does raise autism risk about 1.4 times. The ADA study used the same case-control style but found nothing, showing that not every gene change matters.

Horinouchi et al. (2022) tested UGT1A1 and also saw no link with autism. Together these papers form a line of "no-go" markers you can ignore when talking genes with parents.

Cicchetti et al. (2014) took a different path. They looked at two GABA receptor genes at once and found a positive effect when the markers team up. This tells us single-gene hunts often miss what combo approaches can catch.

You can now tell families that the ADA G22A test gives no useful autism risk information. Save your energy for assessments that track behavior and skill, not this gene. If parents still want genetic clues, point them toward broader panels or microarray studies like Al-Mamari et al. (2015) that find real variants in a quarter of cases with dysmorphic features.